The correlation between DTYMK and the major histocompatibility complex (MHC), immune inhibitors, immune stimulators, chemokines, and receptors expressed in the tumor microenvironment (TME) were also inspected across 30 cancer types (Figures 6B–F; Supplementary File S1). Here, DTYMK is linked to cancer.